Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
Lung Cancer
About this trial
This is an observational trial for Lung Cancer focused on measuring adenocarcinoma of the lung, large cell lung cancer, recurrent non-small cell lung cancer, squamous cell lung cancer, stage IIIB non-small cell lung cancer, stage IV non-small cell lung cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically or cytologically confirmed primary non-small cell lung cancer, including any of the following: Newly diagnosed selected stage IIIB (T4 lesion due to malignant pleural effusion) disease Newly diagnosed stage IV disease Recurrent disease after prior surgery and/or radiotherapy Any of the following cellular subtypes are allowed: Adenocarcinoma Large cell carcinoma Squamous cell carcinoma Unspecified carcinoma Enrolled on protocol JMTO-LC00-03 PATIENT CHARACTERISTICS: Performance status Zubrod 0-1 Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal Not specified PRIOR CONCURRENT THERAPY: Radiotherapy See Disease Characteristics Surgery See Disease Characteristics
Sites / Locations
- Toyohashi Municipal Hospital
- Ichinomiyanishi Hospital
- Asahikawa Medical College
- National Cancer Center Hospital East
- Shikoku Cancer Center Hospital
- National Hospital Organization - Nishigunma National Hospital
- Gunma Cancer Center
- National Hospital Organization - Dohoku National Hospital
- Junshinkai Tsuna Hospital
- Takarazuka Municipal Hospital
- Fujisawa City Hospital
- National Hospital Organization - Minamikyoto Medical Center
- Miyagi Cancer Center
- National Hospital Organization - Okayama Medical Center
- Osaka General Medical Center
- Osaka Kosei Nenkin Hospital
- National Hospital Organization - Osaka National Hospital
- Saitama Cardiovascular and Respiratory Center
- Tokyo Medical University
- Tottori University Hospital
- Koseiren Takaoka Hospital